Pharmaceutical Executive January 19, 2022
Editorial Staff

Artificial intelligence (AI) is a rapidly developing technology, and pharma is catching up fast with an exponential increase in the adoption of machine learning into marketing and sales strategies. When used right, AI has the potential to revolutionize the pharma marketing industry, especially in terms of real-time insights and predictions based on customer data. It’s not a magic bullet though, and pharma must focus on harnessing the power of AI to get the marketing basics right and better engage HCPs through personalized, targeted messaging via the right channels at the right time.

However, the early adopters of this powerful tool are set to reap the benefits and enjoy a significant competitive advantage in the future.

Pharmaceutical Executive caught up with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Pharma / Biotech, Provider, Technology, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article